Clariant to Produce More Medical Plastic Compounds
Clariant International Ltd., Muttenz, Switzerland, will expand its plant in Lewiston, ME/USA and install a new compounding line to help meet growing demand for pre-colored medical plastic compounds that are supplied under the Mevopur brand name. The new capacity will come on-line in Q4 2017.
The new compounding line, built around a new 70-mm extruder, will be able produce larger batch sizes (e.g.: 3000 to 6000kg /6000 to 12000lbs or larger) at high throughput rates. Production will focus on materials such as polyolefins, ABS, PC and PC alloys as well as specialty resins like TPU, and cyclic olefins. The EN-ISO13485 (2012) certified site in Lewiston is also being expanded to improve process-flow and material-handling.
Clariant’s Mevopur materials are offered for applications in medical devices and pharmaceutical packaging, where strict regulations on materials and change control apply. The Lewiston plant is one of three global sites designed and operated to produce materials used in medical devices and pharmaceutical packaging. The other two facilities are located in Malmö, Sweden, and Singapore.
This new capacity complements equipment and plant investments aimed at compounding engineering resins and high-temperature polymers and, most recently, completion of a special installation in Lewiston for processing fluoropolymers such as FEP, ETFE, and PVDF.
Clariant International Ltd.
Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?
Looking for a new challenge? Check out our jobs market!
Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.